Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 1 of 187  |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1 110.0 months Stage I to IIIB breast cancer 4 Chemotherapy
Tokai University School of Medicine Japan 1/2008
Treatment Details: Patients: This phase III study involved 97 women with stage I to IIIB breast cancer. The median age was 46 years, and the majority (74%) of patients were premenopausal. Treatment: All
 
2 104.4 months Locally advanced prostate cancer 4 Biologic therapy
University of California San Francisco United States 2/2008
Treatment Details: Patients: This phase III study involved 456 patients with locally advanced prostate cancer. These patients were divided into two similar groups. The median age was 70 in one group and 71
 
3 102.0 months Bladder Cancer 4 Chemotherapy
Surgery
Sapporo Medical University School of Medicine Japan 6/2014
Treatment Details: Patients: This phase 3 study involved muscle-invasive bladder cancer patients who were divided into two separate treatment groups. Group A consisted of 66 patients with a median age of 63 y
 
4 95.0 months Stage IB NSCLC 4 Chemotherapy
Tufts Medical Center United States 11/2008
Treatment Details: Patients: This study involved 344 patients with stage IB non-small cell lung cancer. These patients ranged in age from 34 to 81 years of age. All had previously had surgery within 4-8 week
 
5 85.3 months Locally advanced and high-risk prostate cancer 4 Chemotherapy
Hormone
Surgery
Technische Universität München Germany 3/2014
Treatment Details: Patients: This phase 2 study involved 30 male, locally advanced and high-risk prostate cancer patients with a median age of 68 years. Treatment: Patients received chemotherapy with doce
 
6 84.0 months Stage III melanoma 5 Immunotherapy
University of El Paso United States 5/2007
Treatment Details: Patients: This trial involved 604 patients with resected stage III cutaneous melanoma. These patients were mostly men (66%), and 96-99% were white. The average age was 48.5 years. Trea
 
7 82.0 months Bladder Cancer 4 Sapporo Medical University School of Medicine Japan 6/2014
Treatment Details: Patients: This phase 3 study involved muscle-invasive bladder cancer patients who were divided into two separate treatment groups. Group A consisted of 66 patients with a median age of 63 y
 
8 81.6 months Mantle cell lymphoma 5 Biologic therapy
Chemotherapy
Hormone
University of Rochester School of Medicine and Dentistry United States 3/2013
Treatment Details: Patients: This phase 2 study involved 49 previously untreated mantle cell lymphoma patients who. The median patient age was 57.4 years and 78% were male. Treatment: Patients were treat
 
9 80.8 months Muscle-Invasive Bladder Cancer 5 Chemotherapy
San Camillo and Forlanini Hospitals Italy 1/2015
Treatment Details: Patients: This phase 3 study involved patients with muscle-invasive urothelial carcinoma of the bladder who had previous radical cystectomy surgery. Patients were divided into two separate
 
10 79.2 months NHL 5 Chemotherapy
Radiation
Memorial Sloan-Kettering Cancer Center United States 11/2013
Treatment Details: Patients: This phase 2 study involved 52 newly diagnosed primary central nervous system lymphoma patients. The median patient age was 60 years and 30 were male. Treatment: Patients wer
 
Page 1 of 187  | Next Page